Life Sciences

• Foley Hoag Represents Dicerna in Recent Collaborations

  October 29, 2018

• Foley Hoag Advises Morphic Therapeutic in $80M Series B Financing

  October 4, 2018

• Foley Hoag Advises Orig3n in Closing of Series B Funding Round

  August 28, 2018

• Foley Hoag Advises Integrated Prescription Management in Growth Investment

  August 21, 2018

• Foley Hoag Represents Organogenesis in Merger with Avista Healthcare Public Acquisition Corp.

  August 17, 2018

• Foley Hoag Advises Alexion Pharmaceuticals in Co-Development Partnership with Complement Pharma

  July 26, 2018

• Foley Hoag Assists PCMA Obtain 8th U.S. Circuit Court of Appeals Victory

  June 14, 2018

• Foley Hoag Advises AurKa Pharma in Sale to Eli Lilly and Company

  June 8, 2018

• 27 Foley Hoag Lawyers Recognized in Chambers USA 2018

  May 4, 2018

• Foley Hoag Mergers & Acquisitions Practice: 2017 Highlights

  April 18, 2018